BDBahar Girgin Dindar

Bahar Girgin Dindar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bahar Girgin Dindar has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Factors associated with health-related quality of life in children with pectus deformities: a cross-sectional study of symptoms, pulmonary function, and self–proxy relationships

    by Ece Ocak, Gökçen Kartal Öztürk, Ece Halis, Bahar Girgin Dindar, Fevziye Çoksüer, Mehmet Mustafa Özaslan, Atacan Öğütçü, Ülküm Zafer Dökümcü, Coşkun Özcan, Figen Gülen

  • Open Access

    Impulse Oscillometry for Pulmonary Function Evaluation in Children with Neuromuscular Disease: A Comparative Study with Spirometry

    by Ece Ocak, Gökçen Kartal Öztürk, Hasan Tekgül, Yavuz Ataş, Ece Halis, Bahar Girgin Dindar, Fevziye Çoksüer, Meral Barlık, Mehmet Mustafa Özaslan, Atacan Öğütçü, et al.


  • Can the HALP Score Be Used as a Prognostic Marker in Paediatric Patients With Cystic Fibrosis?

    by Kübra Özkaya, Gökçen Kartal Öztürk, Bahar Girgin Dindar, Ece Halis, Fevziye Çoksüer, Atacan Öğütcü, Hazal Gacemer, Gülcan Yılbaş Kara, Ece Ocak, Figen Gülen

    Rationale: Cystic fibrosis (CF) is characterised by chronic inflammation and malnutrition, significantly affecting disease progression and prognosis. The haemoglobin‐albumin‐lymphocyte‐platelet (HALP) score reflects inflammatory and nutritional status, and has prognostic associations in various chronic diseases; its role in paediatric CF is unclear. Objective: To evaluate the association between HALP measured during clinical stability and (i) baseline disease severity at the index assessment (FEV 1 , MSKS, and BMI z‐score), and (ii) subsequent 12‐month outcomes (hospitalisation‐requiring pulmonary exacerbations, PICU admission, and mortality) in children with CF. Methods: Retrospective single‐centre cohort study of 152 children with CF aged 2–18 years. HALP was calculated at clinical stability. Associations with index severity and 12‐month outcomes were analysed; logistic regression for low FEV 1 was restricted to participants with acceptable spirometry. Results: Lower HALP was associated with low FEV 1 (< 70% predicted) at the index assessment ( p < 0.001) and with a higher 12‐month burden of hospitalisation ‐requiring pulmonary exacerbations ( p < 0.001). PICU admission and mortality were infrequent and analysed exploratorily; HALP was lower in these groups (PICU p < 0.001; mortality p = 0.004). In adjusted logistic regression among participants with spirometry ( n = 101), HALP remained associated with low FEV 1 , although the effect size was modest and precision limited (adjusted OR 0.886, 95% CI 0.788–0.996; p = 0.043). Conclusions: HALP, reflecting nutritional and inflammatory status, may offer prognostic information in paediatric CF. Calculation from routine blood tests could make it a practical tool for identifying higher‐risk individuals and informing clinical decision‐making. Further large‐scale studies are needed to validate its clinical utility in CF management.

  • Open Access

    Quality of life in Turkish children with interstitial lung disease: Insights from the National chILD Registry

    by Handan Kekec, Tugba Sismanlar Eyuboglu, Ayse Tana Aslan, Ozge Ulgen, Aslıhan Ozcaglar, Zeliha Başak Polat, Betül Bankoglu Parlak, Aysen Bingol, Seyda Karabulut, Ela Erdem Eralp, et al.

    Childhood interstitial lung diseases (chILD) include a diverse range of rare disorders, complex clinical progressions, and high rates of morbidity and mortality. This study aims to assess the clinical and psychosocial impacts of chILD in children registered in the National chILD-Turkiye database. Data from 17 centers were analyzed as of January 2024. Patients aged 1 month to 18 years were included in the study. Through face-to-face interviews, patients and their families completed the Pediatric Quality of Life Inventory (PedsQL™ 4.0 Generic Core Scales) and PedsQL™ 2.0 Family Impact Module. Higher scores suggest better performance and higher health-related quality of life (HRQoL). Patient clinic data, demographic information, pulmonary function tests, Fan scores, and household income were recorded. Patients were categorized into two groups according to their use of O 2 therapy and diffuse progressive lung disease (DPLD) groups A and B. The study included 175 patients (90 girls), with a median age of 7.7 (1.0–17.8) years. A strong positive correlation was found between the FEV1% value and both the Physical Health Summary Score and the Total Score ( p = 0.007, r = 0.608; p = 0.008, r = 0.607). The Fan score negatively correlated with PedsQL™ scores ( p < 0.001). Patients who use O 2 have an earlier diagnosis of age of chILD, lower FEV1%, higher Fan scores, and lower Child Self-Reports and Parent Reports scores ( p < 0.05). The group with DPLD-A disorders has an earlier diagnosis age, lower weight and BMI z-scores, higher Fan score, and higher Family Impact Module score ( p < 0.05). Conclusion : Lung function and Fan score strongly correlate with HRQoL, emphasizing the impact of disease severity on physical and psychosocial well-being. These findings highlight the need for multidisciplinary care and psychosocial support to enhance the QoL in children with chILD and their families. What is Known: • Childhood interstitial lung diseases (chILD) are rare and diverse disorders associated with significant morbidity and complex management. • Evidence regarding health-related quality of life (HRQoL) and the psychosocial burden on affected families remains limited. What is New: • This multicenter national registry–based study provides the first comprehensive evaluation of HRQoL and family impact in children with chILD in Türkiye. • Lung function impairment and higher Fan severity scores were strongly linked to poorerHRQoL, highlighting the influence of disease severity on physical and psychosocial well-being.

  • Fungal colonization and its clinical associations in pediatric cystic fibrosis: A 12-year single-center cohort stud

    by Ece Ocak, Gökçen Kartal Öztürk, Ece Hali̇s, Bahar Gi̇rGi̇n Di̇nDar, Fevziye Çoksüer, Mehmet Mustafa Özaslan, Meral Barlik, Atacan Öğütçü, Figen Gülen

    Fungal organisms are increasingly isolated from respiratory samples of patients with cystic fibrosis (CF), yet their clinical relevance remains incompletely understood. This study aimed to assess the frequency of colonization and clinical characteristics of CF patients with fungal colonization. We retrospectively reviewed CF patients followed at the Pediatric Pulmonology Division of Ege University between January 2011 and December 2022. Those with at least one respiratory culture analyzed for fungi were included. Fungal colonization was defined as the growth of the same species in at least 50% of cultures within one year. Demographic, clinical, spirometric, and microbiological data were evaluated. Among the 98 patients, median age was 9.6 years (1.7-32.1), and 54.1% were male. Fungal growth was detected in 51 patients (52.0%), and 37 (37.7%) met the criteria for colonization. Candida albicans (32.7%) and Aspergillus fumigatus (13.3%) were the most commonly isolated species. Patients with fungal colonization were older (p< 0.001), more likely to have chronic Pseudomonas aeruginosa colonization (p< 0.001), had more inhaled antibiotic use (p< 0.001), CF-related liver disease (p= 0.018), and had lower FEV1% (p= 0.005) and body mass index z-scores (zBMI) (p< 0.001). Regression analyses identified lower zBMI (95% CI: 0.527-0.948; p= 0.021) and P. aeruginosa colonization (95% CI: 1.237-8.809; p= 0.017) as independent predictors of fungal colonization. Fungal colonization is common in children with CF and is associated with older age, impaired lung function, lower zBMI, and P. aeruginosa co-colonization. These findings support the need for routine fungal surveillance and further prospective studies to clarify clinical implications. Further research is needed to determine whether these relationships are causal.

  • Atelectasis in children: Results of flexible fiberoptic bronchoscopy

    by Mehmet Mustafa Özaslan, Gökçen Kartal Öztürk, Meral Barlik, Fevziye Çoksuer, Bahar Gi̇rGi̇n Di̇nDar, Ece Ocak, Ece Hali̇s, Atacan Öğütçü, Figen Gülen

    Pulmonary atelectasis is a significant respiratory problem in children. This study aimed to investigate the underlying causes of atelectasis and evaluate the outcomes of flexible fiberoptic bronchoscopy (FFB) in pediatric patients with this condition. Clinical data and outcomes of 110 children who underwent FFB were retrospectively analyzed based on radiological imaging obtained at three and six months following the procedure, and the patients were categorized into three groups: Group 1 (complete resolution of atelectasis), Group 2 (partial resolution), and Group 3 (no resolution). Between January 2016 and December 2023, a total of 110 pediatric patients with pulmonary atelectasis underwent FFB. The most common bronchoscopic findings were mucus plugs and secretions (50%), foreign body aspiration (7.3%), and congenital airway anomalies (3.6%). In 30% of the patients, bronchoscopy findings were normal. Complete resolution of atelectasis was observed in 55.4% of patients following FFB. The median duration of atelectasis in Group 3 was 90 days, significantly longer than that found in the other two groups (p= 0.002). Additionally, the median hospitalization period prior to bronchoscopy in Group 3 was 21 days, which was also longer than that found in the other groups (p= 0.004). The median atelectasis score in Group 1 was 2.34 (range: 0.9-3.1), significantly lower than in Groups 2 and 3 (p= 0.005). FFB is an effective tool for identifying the etiology of atelectasis in children. Prolonged duration of atelectasis and the presence of comorbidities were identified as risk factors for persistent, non-resolving atelectasis.


  • Impulse oscillometry for evaluating pulmonary function in pediatric pectus deformities: a prospective controlled study

    by Ece Ocak, Ece Halis, Gökçen Kartal Öztürk, Bahar Girgin Dindar, Fevziye Çoksüer, Mehmet Mustafa Özaslan, Atacan Öğütçü, Ülküm Zafer Dökümcü, Coşkun Özcan, Figen Gülen

    Pectus deformities (PDs), including pectus excavatum and pectus carinatum, may affect pulmonary mechanics; however, spirometry often fails to detect subtle abnormalities. This study aimed to evaluate pulmonary function in children with PDs using both spirometry and impulse oscillometry (IOS). In this prospective cross-sectional study, 73 children with PDs and 80 age- and sex-matched healthy controls underwent spirometry and IOS testing. z-scores were calculated for all parameters using established reference equations. A possible restrictive ventilatory defect was defined as zFVC < − 1.645 with normal or elevated zFEV1/zFVC. Children with PDs had significantly lower zFVC and zFEV1 values and higher zAX and zX15 compared with controls (p < 0.001, p = 0.008, p < 0.001, and p = 0.033, respectively). No child exhibited an obstructive pattern, while 61.6% had a possible restrictive ventilatory defect. In multivariate analysis, lower zBMI (OR 0.494; 95% CI 0.286–0.855; p = 0.012) and higher zAX (OR 1.528; 95% CI 1.112–2.100; p = 0.009) independently predicted restriction. ROC analysis identified a zAX cutoff of ≥ 4.97 (AUC 0.671, sensitivity 75.8%, specificity 53.8%). Conclusion: These findings highlight the added value of IOS in detecting respiratory impairment in PDs. The combined use of IOS and spirometry may enable earlier identification of functional limitation, and zAX may serve as a useful marker in clinical decision-making and follow-up planning for affected children. What is Known: • Pectus deformities (PDs) may impair pulmonary function, but spirometry often yields inconsistent results. • Impulse oscillometry is a sensitive, effort-independent tool for assessing respiratory mechanics. What is New: • IOS parameters indicated increased peripheral pulmonary airway reactance (zX5) and zAX, suggesting altered respiratory mechanics, while revealing no evidence of any obstructive pattern on spirometry. • The combined use of IOS and spirometry may be a useful pulmonary function test in clinical decision-making and follow-up planning for children with PDs.


  • Open Access

    Newborn Screening Program for Cystic Fibrosis in Türkiye: Experiences from False-Negative Tests and Requirement for Optimization

    by Fevziye Çoksüer, Gökçen Kartal Öztürk, Handan Duman Şenol, Meral Barlık, Mehmet Mustafa Özaslan, Bahar Girgin Dindar, Ece Ocak, Ece Halis, Şükrü Atacan Öğütcü, Figen Gülen, et al.

    Since January 2015, the Cystic Fibrosis National Newborn Bloodspot Screening (CF-NBS) program has been implemented in Turkey with two samples of immune reactive trypsinogen (IRT-1/IRT-2) testing. This study aimed to evaluate the Turkish national CF screening program, which included patients referred to a tertiary pediatric pulmonology center, to ascertain the optimal cut-off values for IRT-1/IRT-2 and to identify alternative strategies for mitigating the number of late-diagnosed false-negative patients (FNPs) who initially exhibited screen negative results but were diagnosed subsequently based on clinical suspicion. The study also compared NBS-positive patients to FNPs to determine the influence of delayed diagnosis. A retrospective cohort study. Screening for CF was conducted in accordance with the national CF-NBS program within 48-72 hours of birth by collecting a few drops of heel blood on Guthrie paper. A cut-off value of 90 μg/l was accepted for the first IRT, while 70 μg/l was accepted for the second sample. Infants with elevated IRT values in both samples were referred to the CF centers for a sweat test (ST). Based on the diagnosis, the NBS-positive infants referred to our CF center for ST analysis were divided into three groups: CF; cystic fibrosis-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID); and false-positive NBS. In addition, the study included NBS-negative patients who initially received negative screen results but were subsequently diagnosed with CF based on clinical suspicion. Of the 227 NBS-positive infants referred within the study period, 53 (23.34%) were diagnosed with CF (true-positive NBS), 11 were classified as CRMS/CFSPID (4.84%), and 163 were classified as falsepositive NBS (71.8%). CF was diagnosed in 66 infants, 53 (80.3%) of whom were confirmed using the NBS test, while the 13 (19.7%) patients who were missed on the NBS test were diagnosed based on clinical suspicion (FNP). The study findings indicate that the IRT/IRT approach exhibited a sensitivity of 80.3% and a positive predictive value (PPV) of 23.3%. The current study is the first to analyze the NBS program for CF using data from the Western Anatolian Region of Türkiye. Due to the low sensitivity and PPV of the IRT/IRT protocol and the high proportion of false-positive infants and FNPs, the current national program is not practicable for Türkiye. False-negative results significantly delay the diagnosis and invalidate the screening objectives. It is essential to establish optimal cut-off values for IRT-1/IRT-2 or revise existing strategies to reduce the number of FNPs missed by the screening program.


  • Open Access

    Experience of flexible bronchoscopy in the pediatric pulmonary diseases clinic

    by Mehmet Mustafa Özaslan, Gökçen Kartal Öztürk, Meral Barlik, Ece Ocak, Fevziye Çoksuer, Bahar Gi̇rGi̇n Di̇nDar, Atacan Öğütçü, Ece Hali̇s, Esen Demi̇r, Figen Gülen

    Flexible bronchoscopy is a valuable method in the diagnosis and treatment of respiratory tract diseases in children. This study aimed to examine the indications for and results of flexible bronchoscopy in children. The study included patients aged 0-18 years who underwent flexible bronchoscopy between 1 January 2017 and 31 December 2022. The patients were evaluated for demographic characteristics, indications for bronchoscopy, comorbidities, bronchoscopy findings, and the results of bronchoalveolar lavage. During the defined study period, a total of 410 flexible bronchoscopy procedures were performed. 51.9% of the patient population were male, and 48.1% were female, with a mean age of 96.93 ± 63.45 months. The most common indication for flexible bronchoscopy was recurrent lower respiratory tract infection (26.8%), followed by chronic cough (19.1%). The bronchoalveolar lavage culture results showed that the most commonly isolated microorganisms were H. influenzae non-type b (7.8%) followed by M. catarrhalis (7.3%). Mucus obstruction and secretion (33.0%) constituted the most common bronchoscopic findings, while the flexible bronchoscopy examination was normal in 27% of patients. No serious complications occurred in any patient during or after the procedure. The results of this study demonstrated that the most common indication for flexible bronchoscopy was recurrent lower respiratory tract infection and the most common bronchoscopy finding was purulent secretion with mucus obstruction. Flexible bronchoscopy is an important diagnostic and treatment tool for patients with recurrent respiratory symptoms. It is a highly valuable method as it enables direct visualization of the airways and facilitates the collection of bronchoalveolar lavage samples.